Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Clinical Guidelines
Multicancer Detection: The Need for Clinical Guidance
By
Jaffer A. Ajani, MD
;
Al B. Benson III, MD
;
Mary B. Daly, MD, PhD, FACP
;
David S. Ettinger, MD
;
Maria M. Ho, PhD
Clinical Guidelines
October 2021, Vol 12, No 5
Cancer remains the leading cause of death in individuals aged <80 years in the United States, and was responsible for nearly 10 million deaths worldwide in 2020.1,2 According to the National Cancer Institute, the 5-year survival rate for individuals diagnosed with localized cancer of any type is 89%.3 However, this rate drops to only 21% for those diagnosed with metastatic disease,3 highlighting the detrimental impact of late-stage diagnosis on patient outcomes.
Read Article
ASCO/AAHPM Guidance Statement Could Standardize Palliative Care in Oncology
By
Meg Barbor, MPH
Clinical Guidelines
,
Palliative Care
,
Policies & Guidelines
December 2015, Vol 6, No 11
Boston, MA—A new guidance statement from the American Society of Clinical Oncology (ASCO) and the American Academy of Hospice and Palliative Medicine (AAHPM) provides the first formal, consensus-based recommendations regarding high-quality primary palliative care in oncology, according to Kathleen E. Bickel, MD, MPhil, Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH.
Read Article
New Guidelines for Breast Cancer Screening Still Not a Definitive Answer for Women Aged >40 Years
By
Kristen Chanley
Clinical Guidelines
,
Policies & Guidelines
November 2015, Vol 6, No 10
“Especially for average-risk women, decisions to undergo regular mammography screening must also consider the harms of mammography,” stated Nancy L. Keating, MD, MPH, and Lydia E. Pace, MD, MPH.
Read Article
NCCN Incorporates Affordability Criteria in Its Clinical Guidelines to Assess Value of Cancer Therapies
By
Wayne Kuznar
Clinical Guidelines
,
NCCN Conference Highlights
,
Policies & Guidelines
November 2015, Vol 6, No 10
The National Comprehensive Cancer Network (NCCN) has added a new value criterion to its clinical practice guidelines in the form of “Evidence Blocks” for the evaluation of treatment options.
Read Article
NCCN 2011 Clinical Guidelines Updates
By
Robert W. Carlson, MD
Clinical Guidelines
,
NCCN Conference
,
Policies & Guidelines
April 2011, Vol 2, No 2
Chairpersons of the various National Comprehensive Cancer Network (NCCN) tumor panels presented clinical practice updates at the recent 16th Annual Conference of the NCCN. Key updates, and relevant discussions, are highlighted.
Read Article
View the Latest Issue of VBCC
Read Issue
Top Trending Articles
1.
Medication Assurance Programs, as Deceiving and Harmful as Alternate Funding Programs
Dawn Holcombe, MBA, FACMPE, ACHE
2.
Addressing Challenges to Adoption of Value-Based Agreements
Phoebe Starr
3.
Luspatercept Yields Improved Transfusion Independence Compared With Epoetin Alfa in Patients With Lower-Risk MDS
Phoebe Starr
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
SABCS 2023 - HER2+ MBC
ASCO 2023 - Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quizzes
Press Releases
AVBCC
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma